Risk Management


Neuro

Welcome to OMIC’s Neuro-ophthalmology risk management resource library, a comprehensive collection of loss prevention and patient safety resources for ophthalmic practices.

Our resources for Neuro-ophthalmology include model consent forms, risk management articles, closed claim studies, and recommendation and procedure guides.

Articles (5)

Headaches, Jaw Pain and Missed Thrills

Risk Management Issues in Failure to Diagnose Neurologic Illnesses

Take the Risk Out of Intraocular Surgery in Patients with Corneal Dystrophies

2015 Claims Study: Giant cell arteritis claims are costly and difficult to defend

2018 November Bulletin: Giant Cell Arteritis (based on 2015 GCA Claims Study)

Case Studies (11)

Misdiagnosis of a Nevus by an Optometrist Insured with Another Carrier

Watch for Warning Signs of a Missed Diagnosis

Trauma Cases: Risky to Treat, Difficult to Defend

Failure to Diagnose Temporal Arteritis

Failure to Diagnose Toxic Optic Neuropathy

Failure to Diagnose an Occipital Aneurysm

Failure to Diagnose a Brain Lesion in a Referred Patient

Failure to Diagnose Giant Cell Arteritis (1999)

Pseudotumor Cerebri in Young Female

Pseudotumor Cerebri in Young Female

Poor communication between providers delays GCA diagnosis

Consent Forms (2)

Anticoagulant consent form

Texas Consent Requirements Effective 2020

Coverage Issues (0)
Patient Issues (0)
Practice Issues (0)
Recommendations (3)

Idiopathic intracranial hypertension/Pseudotumor cerebri checklist

Giant Cell Arteritis Toolkit (2022)

Giant Cell Arteritis Risk Management Recommendations (2022)



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684